Better Intra-Agency Reviews Could Speed FDA Seizure, Injunction Decisions
This article was originally published in The Tan Sheet
Executive Summary
FDA is working to expedite its decision-making process for seizures and injunctions, which could translate into quicker enforcement actions for violative products.